Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent

被引：0
|
作者：
Buisson, A. [1 ]
Nachury, M. [2 ]
Fumery, M. [3 ]
Guilmoteau, T. [1 ]
Leclerc, E. [1 ]
Altwegg, R. [4 ]
Serrero, M. [5 ]
Mathieu, N. [6 ]
Treton, X. [7 ]
Vuitton, L. [8 ]
Pereira, B. [9 ]
Amiot, A. [10 ]
Bouguen, G. [11 ]
机构：
[1] Univ Hosp Estaing, Dept Gastroenterol, IBD Unit, Clermont Ferrand, France
[2] CHRU Lille, IBD Unit, Lille, France
[3] CHU Amiens, IBD Unit, Amiens, France
[4] CHU Montpellier, IBD Unit, Montpellier, France
[5] AP HM, IBD Unit, Marseille, France
[6] CHU Grenoble, IBD Unit, Grenoble, France
[7] AP HP Beaujon Hosp, IBD Unit, Paris, France
[8] CHU Besancon, IBD Unit, Besancon, France
[9] Univ Hosp Estaing, DRCI Biostat Unit, Clermont Ferrand, France
[10] AP HP Creteil Hosp, IBD Unit, Paris, France
[11] CHU Rennes, IBD Unit, Rennes, France
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP76
引用
收藏
页码：I120 / I120
页数：1
相关论文
共 50 条
  • [41] Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
    Straatmijer, Tessa
    Biemans, Vince B. C.
    Visschedijk, Marijn
    Hoentjen, Frank
    de Vries, Annemarie
    van Bodegraven, Adriaan A.
    Bodelier, Alexander
    de Boer, Nanne K. H.
    Dijkstra, Gerard
    Festen, Noortje
    Horjus, Carmen
    Jansen, Jeroen M.
    Jharap, Bindia
    Mares, Wout
    van Schaik, Fiona D. M.
    Ponsioen, Cyriel
    Romkens, Tessa
    Srivastava, Nidhi
    van der Voorn, Michael M. P. J. A.
    West, Rachel
    van der Woude, Janneke
    Wolvers, Marije D. J.
    Pierik, Marieke
    van der Meulen-de Jong, Andrea E.
    Duijvestein, Marjolijn
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (01) : 182 - +
  • [42] Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study
    Meyer, Antoine
    Fumery, Mathurin
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Altwegg, Romain
    Bouhnik, Yoram
    Serrero, Melanie
    Laharie, David
    Roblin, Xavier
    Nachury, Maria
    Abitbol, Vered
    Cadiot, Guillaume
    Nancey, Stephane
    Allez, Matthieu
    Gilletta, Cyrielle
    Vuitton, Lucine
    Savoye, Guillaume
    Nahon, Stephane
    Bourrier, Anne
    Buisson, Anthony
    Bouguen, Guillaume
    Bourreille, Arnaud
    Viennot, Stephanie
    Carbonnel, Franck
    Amiot, Aurelien
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (12) : 1454 - 1462
  • [43] Comparison of the efficacy of a second intravenous or subcutaneous anti-TNF in the treatment of ulcerative colitis: Real-world data from the ENEIDA registry
    Torres-Rodriguez, P.
    Canete, F.
    Calafat, M.
    Sanchez-Aldehuelo, R.
    Rivero, M.
    Iborra, M.
    Gonzalez-Vivo, M.
    Vera, I.
    de Castro, L.
    Bujanda, L.
    Barreiro-de Acosta, M.
    Calvet, X.
    Benitez, J. M.
    Llorente, M.
    Suris, G.
    Arias-Garcia, L.
    David, M.
    Castano-Garcia, A.
    Garcia-Alonso, F. J.
    Rufo, L.
    Ferrer, J. A.
    Camo, P.
    Gisbert, J. P.
    Huguet, J. M.
    Pajares, R.
    Morales, V.
    Llao, J.
    Rodriguez, A.
    Rodriguez, C.
    Navarro, M.
    Gomollon, F.
    Carrillo-Palau, M.
    Sese, E.
    Almela, P.
    Ramirez de la Piscina, P.
    Rodriguez-Lago, I.
    Papo, M.
    Vela, M.
    Manosa, M.
    Domenech, E.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S463 - S464
  • [44] Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis
    Taxonera, Carlos
    Olivares, David
    Alba, Cristina
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (01) : 32 - 40
  • [45] COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB VS ANTI-TNFs IN ULCERATIVE COLITIS BIO-NAIVE PATIENTS AND PATIENTS WITH FAILURE OF ONE PREVIOUS ANTI-TNFα (EVOLVE-IBERIA STUDY)
    Casellas Jorda, F.
    Rodriguez, C.
    Gisbert, J. P.
    Bernardo, S.
    Aparicio, J.
    Tagarro, I.
    Munoz, F.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 912 - 913
  • [46] Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
    Cassandra Rayer
    Maria Nachury
    Arnaud Bourreille
    Xavier Roblin
    Laurent Peyrin-Biroulet
    Stephanie Viennot
    Mathurin Flamant
    David Laharie
    Bénédicte Caron
    Marie Dewitte
    Laurent Siproudhis
    Mathurin Fumery
    Guillaume Bouguen
    BMC Gastroenterology, 22
  • [47] 1-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United States
    Dalal, Rahul S.
    Sharma, Puza P.
    Bains, Kanwal
    Pruce, Jordan C.
    Allegretti, Jessica R.
    INFLAMMATORY BOWEL DISEASES, 2023, 30 (08) : 1419 - 1422
  • [48] Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study
    Cassandra, Rayer
    Nachury, Maria
    Arnaud, Bourreille
    Xavier, Roblin
    Laurent, Peyrin-Biroulet
    Stephanie, Viennot
    Mathurin, Flamant
    David, Laharie
    Benedicte, Caron
    Marie, Dewitte
    Laurent, Siproudhis
    Mathurin, Fumery
    Guillaume, Bouguen
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [49] A real-world observational study assessing treatment persistence in ulcerative colitis patients receiving anti-TNF treatment (golimumab or adalimumab)
    Hoque, S.
    Boccaletti, S.
    Puenpatom, A.
    Brown, C.
    Black, C.
    Roberts, J.
    Rajkovic, I.
    Milligan, G.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S394 - S394
  • [50] Decreased leukocyte trafficking may contribute to vedolizumab refractory disease after anti-TNF exposure in patients with ulcerative colitis
    Verstockt, B.
    Verstockt, S.
    de Bruyn, M.
    Machiels, K.
    Blevi, H.
    Ballet, V.
    Van Assche, G.
    Vermeire, S.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S113 - S113
12345